% | $
Quotes you view appear here for quick access.

Alnylam Pharmaceuticals, Inc. Message Board

  • rnai_inv rnai_inv Nov 15, 2012 9:47 AM Flag

    article on ALNY

    "Alnylam's prospects are fading, and as it loses ground to rivals such as ISIS and Tekmira in the still unproven field of RNAi technology, it is hard to imagine that Alnylam's near billion dollar valuation can be sustained. Shares could fall sharply in coming weeks as investors come to grips with Alnylam's darkening prospects."

36.6750.000(0.00%)Oct 21 4:00 PMEDT